Medical Weight Loss

Retatrutide

The next-generation triple agonist.

GLP-1, GIP, and Glucagon receptors, all at once.

Retatrutide is the next generation of weight-loss medicine. It's a triple agonist, hitting GLP-1, GIP, and Glucagon receptors simultaneously for advanced metabolic optimization. The result is appetite control, energy balance, and sustained fat loss at levels we haven't seen from earlier GLP-1 protocols. Clinical work shows participants achieving 22 to 24% body-weight reduction over a sustained course. One injection per week. As with all of our weight-loss protocols, Retatrutide is delivered under medical supervision.

Key Benefits
  • Triple-pathway receptor activity for advanced fat loss
  • Strong appetite control and energy balance
  • Higher average weight-loss outcomes than first-generation GLP-1s
  • Once-weekly dosing
Active Ingredients
Retatrutide
Note: Average weight loss: 22 to 24% body weight on a sustained protocol. Dosing is set by your clinician at consult.

Book your appointment.

Available at both Sarasota and Venice clinics. Same-week appointments often available for retatrutide.